Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia.
about
Pathophysiological power of improper tonic GABA(A) conductances in mature and immature models.Cortical parvalbumin interneurons and cognitive dysfunction in schizophreniaMaternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons.GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.Expression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorderAdolescent onset of cortical disinhibition in schizophrenia: insights from animal models.Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats.Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophreniaPhosphorylation of GABAA receptors influences receptor trafficking and neurosteroid actions.Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia.Protein kinase C phosphorylation regulates membrane insertion of GABAA receptor subtypes that mediate tonic inhibition.Neurodevelopment, GABA system dysfunction, and schizophreniaAltered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbanceDevelopmental Expression Patterns of GABAA Receptor Subunits in Layer 3 and 5 Pyramidal Cells of Monkey Prefrontal CortexGenetics and function of neocortical GABAergic interneurons in neurodevelopmental disordersDistinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder.Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia.Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.Are extrasynaptic GABAA receptors important targets for sedative/hypnotic drugs?Using human brain imaging studies as a guide toward animal models of schizophrenia.Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysisFunctional hierarchy underlies preferential connectivity disturbances in schizophrenia.Assessment of subunit-dependent direct gating and allosteric modulatory effects of carisoprodol at GABA(A) receptors.Differential regulation of synaptic and extrasynaptic α4 GABA(A) receptor populations by protein kinase A and protein kinase C in cultured cortical neurons.GABAergic Function as a Limiting Factor for Prefrontal Maturation during Adolescence.α4βδ GABAA receptors and tonic inhibitory current during adolescence: effects on mood and synaptic plasticityThe contribution of δ subunit-containing GABAA receptors to phasic and tonic conductance changes in cerebellum, thalamus and neocortexFunction and modulation of delta-containing GABA(A) receptorsInsights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitryThe inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline.Perisomatic inhibition and cortical circuit dysfunction in schizophrenia.Anticonvulsive evaluation of THIP in the murine pentylenetetrazole kindling model: lack of anticonvulsive effect of THIP despite functional δ-subunit-containing GABAA receptors in dentate gyrus granule cells.Prefrontal cortical GABAergic signaling and impaired behavioral flexibility in aged F344 rats.Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine FunctionRescue of deficient amygdala tonic γ-aminobutyric acidergic currents in the Fmr-/y mouse model of fragile X syndrome by a novel γ-aminobutyric acid type A receptor-positive allosteric modulator.GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies.Is the GABA System Related to the Social Competence Improvement Effect of Aripiprazole? An (18)F-Fluoroflumazenil PET Study.Primate-specific origins and migration of cortical GABAergic neurons.Characterization of GABAA receptor ligands with automated patch-clamp using human neurons derived from pluripotent stem cellsEndogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism.
P2860
Q21129461-00D86D0E-C83D-49AD-B0F6-85FB1C223DEEQ26822851-1DB722F1-3EF2-4965-BDA2-BF0C22D7CD88Q27319478-1DAD4884-95D9-4D2F-A778-22058301D290Q30363617-2B9CE329-5F23-443C-AE0F-FF89D6CA3F01Q30448885-4946586F-6FD4-451D-81B2-5EC42DC4A59EQ30468184-8089C49C-C482-4BAE-9900-650062FA04F3Q30477203-79847EB2-6056-4E3A-9F2C-2C129BF137D0Q30499642-1FFD6BF6-2DAC-405F-A0C7-E09EA6D63EC1Q34053899-8AF68B45-DCDA-4857-A5BB-A50F1C3170DCQ34179419-5EEA87DC-E99E-42F0-A5EA-DB44AEE3D2ECQ34438954-A147350D-4C19-4570-9DE2-CDE899C8864FQ34675943-5D51C1D0-8A9E-4151-B204-3A76A10085A3Q34700955-B70B0DEF-BEFE-4E57-8A0D-97A3317DED1DQ35115046-3F11D04F-4E0F-4078-92FA-2FD15269659DQ35173644-2EB2785F-5205-493D-993C-1CC247A823C9Q35538457-545F9FFC-E16C-483A-8C01-6C0E92DABD41Q35915861-D3D42883-B13F-4C4A-9BED-E7EB9F49F2A1Q36101696-36839302-A5BC-4D6B-A9AC-56EED489BC0CQ36207476-FA3E7EA6-7158-4C33-B82D-368A3292F0A7Q36332602-3D0546A4-CACD-412D-B5E9-CE4254CFC4D2Q36393853-32D50134-D529-451E-BA8B-4E00CCC2894FQ36483365-A24C356B-EC75-4784-B29A-162EA9D07F0AQ36533714-ACF331D3-65CC-472B-994C-96ADE4E52270Q36917978-90FCA259-3D67-4280-B365-361DC790E30DQ37059869-EB831078-D9BA-4741-B8E6-BFE8C629E546Q37138725-7370446E-21DE-452A-B07C-9EDCD10A21B8Q37408496-CCE3D5FB-0BD5-4D08-9D9D-0E18BEA255C3Q37600250-5DB5BF89-A997-4C75-971E-7AA2F596C5E1Q37783378-FEFDB06C-1667-4E16-A720-CCBC2CABBB65Q37784829-87395C16-BD87-45B1-A249-46274978B128Q37890652-09B34101-F8C2-456E-BA66-EFA865156114Q38626006-106E8B19-0A6A-4059-AFF9-CAF69C4745A9Q40000469-68FCF119-B5AA-45D1-B67B-CA316EBA42A3Q41201772-5BAD135E-7271-4316-899D-DB0C6D16D254Q41258644-8033290B-8FA1-4561-8316-FD9A5DD96912Q41370905-0E95E179-C952-4F33-8FD4-1E535984037FQ41513402-9EABE792-213B-4A86-A262-6B8DA23F9D9EQ42076977-B1205315-FBF7-43DF-B8A2-B9A73D8DE495Q42756275-3A123256-5409-4906-886A-372DAB0C0A06Q47369108-538A795D-5883-48F3-A2F7-BE5A5A1617A0
P2860
Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Altered markers of tonic inhib ...... f subjects with schizophrenia.
@ast
Altered markers of tonic inhib ...... f subjects with schizophrenia.
@en
type
label
Altered markers of tonic inhib ...... f subjects with schizophrenia.
@ast
Altered markers of tonic inhib ...... f subjects with schizophrenia.
@en
prefLabel
Altered markers of tonic inhib ...... f subjects with schizophrenia.
@ast
Altered markers of tonic inhib ...... f subjects with schizophrenia.
@en
P2093
P2860
P1476
Altered markers of tonic inhib ...... f subjects with schizophrenia.
@en
P2093
A Leslie Morrow
Allison A Curley
Amy J Ramsey
David W Volk
Jaime G Maldonado-Avilés
Takanori Hashimoto
P2860
P304
P356
10.1176/APPI.AJP.2008.08101484
P407
P577
2009-03-16T00:00:00Z